Skip to content

Untying the Gordian Knot: Exploring Novel Treatments and Future
Prospects in TNBC ~ Patient Case Simulation
*Pre-assessment*

Before you view this activity, please take this pre-assessment. Taking this pre-assessment does not immediately qualify learners to earn credit. 

Certificates of credit will only be sent to learners who also receive a passing score on the post-test (separate from this survey), and fill out the evaluation form and application for credit.
1.What are your credentials?(Required.)
2.What is your community of practice?
3.What contributes to increased mortality risk among African American/Black patients vs White patients w/ TNBC?(Required.)
4.Which of the following are the correct target and payload of sacituzumab govitecan?(Required.)
5.How often should patients receiving T-DXd be monitored for development of ILD with a chest CT 🫁?(Required.)
6.Your 50-old patient with mTNBC has stable disease after completing 4 cycles of sacituzumab govitecan. How should you manage her?(Required.)
7.You have a 58-year-old patient who is starting on sacituzumab govitecan after her mTNBC progressed on doxorubicin. Her baseline labs are within normal limits. Which grade 3 adverse events is she most likely to develop?(Required.)
8.Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity). 

Completing the fields below does not immediately qualify you for a CME certificate. Only after completing the post-survey & evaluation form will a certificate be issued.

*Please note that we will not forward or sell your contact information.
Privacy & Cookie Notice